afluditen 25mg/ml injekční roztok
bb pharma a.s., praha array - 2229 flufenazin-dekanoÁt - injekční roztok - 25mg/ml - flufenazin
pepaxti
oncopeptides ab - melphalan flufenamide hydrochloride - mnohočetný myelom - antineoplastická činidla - pepaxti is indicated, in combination with dexamethasone, for the treatment of adult patients with multiple myeloma who have received at least three prior lines of therapies, whose disease is refractory to at least one proteasome inhibitor, one immunomodulatory agent, and one anti-cd38 monoclonal antibody, and who have demonstrated disease progression on or after the last therapy. for patients with a prior autologous stem cell transplantation, the time to progression should be at least 3 years from transplantation (see section 4.
acidum ascorbicum bbp 100mg/ml injekční roztok
bb pharma a.s., praha array - 102 kyselina askorbovÁ - injekční roztok - 100mg/ml - kyselina askorbovÁ (vitamin c)
vitamin c injektopas 150mg/ml koncentrát pro infuzní roztok
pascoe pharmazeutische praparate gmbh, giessen array - 102 kyselina askorbovÁ - koncentrát pro infuzní roztok - 150mg/ml - kyselina askorbovÁ (vitamin c)
additiva vitamin c blutorange 1000mg šumivá tableta
dr. b. scheffler nachf. gmbh & co.kg, bergisch gladbach array - 102 kyselina askorbovÁ - Šumivá tableta - 1000mg - kyselina askorbovÁ (vitamin c)
additiva vitamin c zitrone 1000mg šumivá tableta
dr. b.scheffler gmbh, bergisch gladbach array - 102 kyselina askorbovÁ - Šumivá tableta - 1000mg - kyselina askorbovÁ (vitamin c)
dehorsan 500mg/200mg/4mg šumivé granule
natur produkt zdrovit sp. z o.o., varšava array - 1064 paracetamol; 102 kyselina askorbovÁ; 329 chlorfenamin-maleinÁt - Šumivé granule - 500mg/200mg/4mg - paracetamol, kombinace kromĚ psycholeptik
dehorsan 500mg/200mg/4mg šumivá tableta
natur produkt zdrovit sp. z o.o., varšava array - 1064 paracetamol; 102 kyselina askorbovÁ; 329 chlorfenamin-maleinÁt - Šumivá tableta - 500mg/200mg/4mg - paracetamol, kombinace kromĚ psycholeptik
ontilyv
bial portela & companhia s.a. - opicapone - parkinsonova choroba - antiparkinsonické léky - ontilyv is indicated as adjunctive therapy to preparations of levodopa/ dopa decarboxylase inhibitors (ddci) in adult patients with parkinson’s disease and end-of-dose motor fluctuations who cannot be stabilised on those combinations.